Bionexus Gene Lab (BGLC) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Bionexus Gene Lab Corp   (NASDAQ: BGLC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Bionexus Gene Lab Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bionexus Gene Lab 's inventory turnover ratio, the ratio that measures Bionexus Gene Lab 's ability to manage its supply chain, sequentially decreased to 3.65 in the second quarter 2026, which does not come as a surprise, as the Bionexus Gene Lab continue to experience headwinds, which also impact its supply chain. Bionexus Gene Lab 's average inventory processing period in the Jun 30 2026 quarter, has increased to 100 days, from 71 days, in the Mar 31 2026 quarter.

Within Healthcare sector 121 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 659 in the first quarter 2026, to 756.

BGLC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bionexus Gene Lab Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BGLC Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -46.29 % -43.42 % -51.27 % -27.47 % 17.68 %
Y / Y Cost of Sales Growth -96.66 % -98.68 % -77.98 % -5.98 % 12.24 %
Inventory Turnover Ratio (TTM) 3.65 5.12 6.22 6.73 6.34
BGLC's Total Ranking # 756 # 659 # 553 # 527 # 553
Average inventory processing period 100 71 59 54 58
Seq. Inventory Growth -2.14 % -1.41 % -32.83 % -17.12 % 3.09 %
Seq. Cost of Sales Growth 167.32 % -95.15 % -77.48 % 14.48 % 5.5 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 11
Healthcare Sector # 122
Overall Market # 756

Inventory Turnover Ratio Statistics
High Average Low
31.61 8.51 3.15
(Dec 31 2020)   (Jun 30 2026)



BGLC Company Profile >> Back to BGLC Efficiency Comparisons >> Compare BGLC Inventory Turnover Ratio to its Competitors

Financial Statements
Bionexus Gene Lab 's Inventories $ 1 Millions Visit BGLC's Balance sheet
Bionexus Gene Lab 's Cost of Revenues TTM $ 3 Millions Visit BGLC's Income Statement
What are BGLC's Sales? Visit BGLC's Sales by Segment

Other Inventory Turnover Ratios
Bionexus Gene Lab 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BGLC's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BGLC's Competitors
Inventory Turnover Ratio for BGLC's Suppliers
Inventory Turnover Ratio for BGLC's Customers

You may also want to know
BGLC's Sales Growth Rates BGLC's Pe Price to earnings ratio BGLC's Receivables Turnover Ratio BGLC's Stock Quote
BGLC's Net Income Growth Rates BGLC's Ps Price to Sales ratio BGLC's Sales per Employee BGLC's Asset Turnover Ratio
BGLC's Net Margin BGLC's Pb Price to Book ratio BGLC's Financial Strength Ratios BGLC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions

Date modified: 2026-08-17T17:18:54+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.